303 related articles for article (PubMed ID: 23418294)
1. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
[TBL] [Abstract][Full Text] [Related]
2. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.
Kim EK; Lee SC; Chang SA; Jang SY; Kim SM; Park SJ; Choi JO; Park SW; Jeon ES; Choe YH
J Cardiovasc Magn Reson; 2020 May; 22(1):30. PubMed ID: 32366254
[TBL] [Abstract][Full Text] [Related]
4. Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by
Yalçin H; Valenta I; Yalçin F; Corona-Villalobos C; Vasquez N; Ra J; Kucukler N; Tahari A; Pozios I; Zhou Y; Pomper M; Abraham TP; Schindler TH; Abraham MR
Am J Cardiol; 2016 Dec; 118(12):1908-1915. PubMed ID: 27771003
[TBL] [Abstract][Full Text] [Related]
5. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
6. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography.
Karamitsos TD; Leccisotti L; Arnold JR; Recio-Mayoral A; Bhamra-Ariza P; Howells RK; Searle N; Robson MD; Rimoldi OE; Camici PG; Neubauer S; Selvanayagam JB
Circ Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 19920032
[TBL] [Abstract][Full Text] [Related]
7. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.
Tyan CC; Armstrong S; Scholl D; Stirrat J; Blackwood K; El-Sherif O; Thompson T; Wisenberg G; Prato FS; So A; Lee TY; Drangova M; White JA
Circ Cardiovasc Imaging; 2013 Mar; 6(2):229-38. PubMed ID: 23413422
[TBL] [Abstract][Full Text] [Related]
8. Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.
Villa AD; Sammut E; Zarinabad N; Carr-White G; Lee J; Bettencourt N; Razavi R; Nagel E; Chiribiri A
J Cardiovasc Magn Reson; 2016 Jan; 18():4. PubMed ID: 26767610
[TBL] [Abstract][Full Text] [Related]
9. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.
Bietenbeck M; Florian A; Shomanova Z; Meier C; Yilmaz A
Clin Res Cardiol; 2018 Nov; 107(11):1062-1070. PubMed ID: 29774406
[TBL] [Abstract][Full Text] [Related]
10. Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner.
Patriki D; von Felten E; Bakula A; Giannopoulos AA; Kamani CH; Schwyzer M; Messerli M; Benz DC; Gebhard C; Gräni C; Pazhenkottil AP; Kaufmann PA; Fuchs TA; Buechel RR
J Cardiovasc Magn Reson; 2021 Jan; 23(1):3. PubMed ID: 33407586
[TBL] [Abstract][Full Text] [Related]
11. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
[TBL] [Abstract][Full Text] [Related]
12. Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events.
Indorkar R; Kwong RY; Romano S; White BE; Chia RC; Trybula M; Evans K; Shenoy C; Farzaneh-Far A
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1686-1695. PubMed ID: 30409558
[TBL] [Abstract][Full Text] [Related]
13. CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol.
Bettencourt N; Ferreira ND; Leite D; Carvalho M; Ferreira WDS; Schuster A; Chiribiri A; Leite-Moreira A; Silva-Cardoso J; Nagel E; Gama V
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1062-1071. PubMed ID: 24011773
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.
Raphael CE; Cooper R; Parker KH; Collinson J; Vassiliou V; Pennell DJ; de Silva R; Hsu LY; Greve AM; Nijjer S; Broyd C; Ali A; Keegan J; Francis DP; Davies JE; Hughes AD; Arai A; Frenneaux M; Stables RH; Di Mario C; Prasad SK
J Am Coll Cardiol; 2016 Oct; 68(15):1651-1660. PubMed ID: 27712778
[TBL] [Abstract][Full Text] [Related]
15. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a
Sciagrà R; Calabretta R; Cipollini F; Passeri A; Castello A; Cecchi F; Olivotto I; Pupi A
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):866-875. PubMed ID: 28050630
[TBL] [Abstract][Full Text] [Related]
16. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
[TBL] [Abstract][Full Text] [Related]
17. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
[TBL] [Abstract][Full Text] [Related]
18. Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy.
Sciagrà R
Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):354-61. PubMed ID: 27611709
[TBL] [Abstract][Full Text] [Related]
19. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact.
Aguiar Rosa S; Rocha Lopes L; Fiarresga A; Ferreira RC; Mota Carmo M
Microcirculation; 2021 Jan; 28(1):e12656. PubMed ID: 32896949
[TBL] [Abstract][Full Text] [Related]
20. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
Rijnierse MT; de Haan S; Harms HJ; Robbers LF; Wu L; Danad I; Beek AM; Heymans MW; van Rossum AC; Lammertsma AA; Allaart CP; Knaapen P
Circ Cardiovasc Imaging; 2014 Jan; 7(1):20-30. PubMed ID: 24343851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
